Patents by Inventor Robert Cafferkey

Robert Cafferkey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050148008
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic ovary cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovary tissue, identifying ovary tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovary tissue for treatment and research.
    Type: Application
    Filed: February 14, 2005
    Publication date: July 7, 2005
    Inventors: Susana Salceda, Roberto Macina, Ping Hu, Herve Recipon, Kalpana Karra, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20050147556
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Application
    Filed: August 30, 2004
    Publication date: July 7, 2005
    Inventors: Shujath Ali, Yongming Sun, Susana Salceda, Herve Recipon, Robert Cafferkey
  • Patent number: 6902892
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: June 7, 2005
    Assignee: diaDexus, Inc.
    Inventors: Susan Salceda, Herve Recipon, Robert Cafferkey
  • Publication number: 20050106620
    Abstract: The present invention provides new markers and methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating cancer.
    Type: Application
    Filed: December 27, 2004
    Publication date: May 19, 2005
    Inventors: Susana Salceda, Robert Cafferkey, Xing Lou, Herve Recipon, Yongming Sun
  • Publication number: 20050084899
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.
    Type: Application
    Filed: December 6, 2004
    Publication date: April 21, 2005
    Inventors: Susana Salceda, Roberto Macina, Herve Recipon, Robert Cafferkey, Yongming Sun, Chenghua Liu, Leah Turner
  • Publication number: 20050079483
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging and prognosticating prostate cancer.
    Type: Application
    Filed: September 13, 2004
    Publication date: April 14, 2005
    Inventors: Shujath Ali, Susana Salceda, Yongming Sun, Robert Cafferkey
  • Publication number: 20050048559
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.
    Type: Application
    Filed: October 5, 2004
    Publication date: March 3, 2005
    Inventors: Susana Salceda, Roberto Macina, Herve Recipon, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Patent number: 6861215
    Abstract: The present invention provides a new method for detecting, diagnosing, monitoring, staging and prognosticating prostate cancer.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: March 1, 2005
    Assignee: diaDexus, Inc.
    Inventors: Shujath Ali, Susana Salceda, Yongming Sun, Robert Cafferkey
  • Patent number: 6855517
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.
    Type: Grant
    Filed: November 20, 2001
    Date of Patent: February 15, 2005
    Assignee: diaDexus, Inc.
    Inventors: Susana Salceda, Roberto A. Macina, Herve E. Recipon, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20050009086
    Abstract: The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Application
    Filed: August 16, 2004
    Publication date: January 13, 2005
    Inventors: Susan Salceda, Herve Recipon, Robert Cafferkey
  • Patent number: 6787335
    Abstract: The present invention provides polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. In addition, antibodies immunospecific for these markers are provided. Vectors, hosts cells and methods for producing these markers, as well as methods and tools for using these markers in detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating mammary gland cancer are also provided.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: September 7, 2004
    Assignee: diaDexus, Inc.
    Inventors: Susana Salceda, Ping Hu, Herve Recipon, Robert Cafferkey
  • Patent number: 6737040
    Abstract: The present invention provides a new method of detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating breast cancer.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: May 18, 2004
    Assignee: diaDexus, Inc.
    Inventors: Yongming Sun, Herve Recipon, Robert Cafferkey
  • Publication number: 20040058319
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic ovary cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovary tissue, identifying ovary tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovary tissue for treatment and research.
    Type: Application
    Filed: November 20, 2001
    Publication date: March 25, 2004
    Inventors: Susana Salceda, Roberto Macina, Herve E. Recipon, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20030194739
    Abstract: The present invention provides new markers and methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer.
    Type: Application
    Filed: May 8, 2003
    Publication date: October 16, 2003
    Inventors: Shujath Ali, Robert Cafferkey, Herve Recipon, Yongming Sun
  • Publication number: 20030180726
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic ovary cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovary tissue, identifying ovary tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovary tissue for treatment and research.
    Type: Application
    Filed: February 13, 2002
    Publication date: September 25, 2003
    Inventors: Susana Salceda, Roberto A. Macina, Ping Hu, Herve E. Recipon, Kalpana Karra, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20030176672
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.
    Type: Application
    Filed: February 12, 2002
    Publication date: September 18, 2003
    Inventors: Susana Salceda, Roberto A. Macina, Ping Hu, Herve E. Recipon, Kalpana Karra, Robert Cafferkey, Chenghua Liu, Yongming Sun
  • Publication number: 20030096238
    Abstract: The invention relates to OSG polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
    Type: Application
    Filed: August 17, 2001
    Publication date: May 22, 2003
    Inventors: Susana Salceda, Robert Cafferkey
  • Publication number: 20030092898
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and noncancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.
    Type: Application
    Filed: February 12, 2002
    Publication date: May 15, 2003
    Inventors: Susana Salceda, Roberto A. Macina, Ping Hu, Herve E. Recipon, Kalpana Karra, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20030044815
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic breast cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast cancer and non-cancerous disease states in breast tissue, identifying breast tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered breast tissue for treatment and research.
    Type: Application
    Filed: February 14, 2002
    Publication date: March 6, 2003
    Inventors: Susana Salceda, Roberto Macina, Ping Hu, Herve E. Recipon, Kalpana Karra, Robert Cafferkey, Yongming Sun, Chenghua Liu
  • Publication number: 20030031678
    Abstract: The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic prostate cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease states in prostate, identifying prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered prostate tissue for treatment and research.
    Type: Application
    Filed: September 19, 2001
    Publication date: February 13, 2003
    Inventors: Shujath Ali, Herve E. Recipon, Robert Cafferkey, Yongming Sun